drugset / Trial / NCT06974617
Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.
Timeline
- Start
- 2025-05-15
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 100 iu | Intramuscular |
| Subject | Lidocaine | Other / unclassified | 2 ml | Intranasal |
| Subject | Lidocaine | Other / unclassified | 2 % | Intranasal |